Product NDC: | 65862-019 |
Proprietary Name: | Cephalexin |
Non Proprietary Name: | Cephalexin |
Active Ingredient(s): | 500 mg/1 & nbsp; Cephalexin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-019 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065253 |
Marketing Category: | ANDA |
Start Marketing Date: | 20051116 |
Package NDC: | 65862-019-20 |
Package Description: | 20 CAPSULE in 1 BOTTLE (65862-019-20) |
NDC Code | 65862-019-20 |
Proprietary Name | Cephalexin |
Package Description | 20 CAPSULE in 1 BOTTLE (65862-019-20) |
Product NDC | 65862-019 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cephalexin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20051116 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | CEPHALEXIN |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |